MI:RNA
PrivateLast Round
Series A
Extension
Dec 10, 2025
Total Funding Raised
$7.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
MI:RNA operates in Healthcare & Life Sciences and is based in Dundee. Its latest recorded funding round was a Series A Extension round in December 2025.
MI:RNA is a veterinary diagnostics company that develops a platform using microRNA biomarkers and artificial intelligence for early disease detection in animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MI:RNA Comparables
Compare MI:RNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuvet Biotech | 71% | |
| Mars, Incorporated | 70% | |
| Moichor | 68% |
For institutional investors. Book with your work email.
MI:RNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 10, 2025 | ||||
| Grant | Oct 14, 2025 | ||||
| Series A | Jul 3, 2024 |
For institutional investors. Book with your work email.
MI:RNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Digitalis Ventures | Series A |
| Veterinary Angel Network for Entrepreneurs | Series A, Series A Extension |
| Gabriel Investments Ltd | Series A, Series A Extension, Seed |
| Equity Gap | Series A, Series A Extension, Seed |
| Ani.VC | Series A Extension |
| Animal Health Angels | Series A, Series A Extension |
| NovaQuest Capital Management | Series A Extension, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
Grew 15% QoQ, from 26 to 30 employees.
- Feb 9, 2026
Grew 17% QoQ, from 24 to 28 employees.
For institutional investors. Book with your work email.
MI:RNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MI:RNA's valuation, stock price, and market status.
Is MI:RNA a public or private company?
MI:RNA is a private company.
What is the current stock price of MI:RNA?
MI:RNA is a private company, so its shares have no public market price. Caplight tracks MI:RNA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MI:RNA worth (valuation)?
Valuation information for MI:RNA is not publicly available.
Can I buy MI:RNA stock?
MI:RNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MI:RNA's last funding round?
MI:RNA's most recent funding round was Series A Extension on December 10, 2025.
Who are the main investors in MI:RNA?
Key investors in MI:RNA include NovaQuest Capital Management.
Will MI:RNA IPO soon?
No public IPO plans have been announced for MI:RNA.
How can I track MI:RNA secondary market activity?
Caplight tracks bids, offers, and trades in MI:RNA's shares on secondary markets.